Justin D. Gover is CEO at GW PHARMACEUTICALS PLC (GWPH). They have made 12 open-market trades across 1 company since 2019, most recently 2026-06-01.
CIK 0001754129
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GWPH | SELL | 2020-11-13 | 2020-11-17 | $10.02 | $1.9M | +15.4% | -2.7% | +75.9% |
| GWPH | SELL | 2020-11-09 | 2020-11-12 | $10.01 | $1.4M | +9.3% | +2.4% | +81.6% |
| GWPH | SELL | 2020-03-02 | 2020-03-04 | $8.32 | $477K | -28.2% | -18.9% | +26.2% |
| GWPH | SELL | 2020-02-26 | 2020-02-28 | $9.03 | $194K | -15.1% | -16.8% | +22.5% |
| GWPH | SELL | 2020-02-03 | 2020-02-05 | $9.62 | $3.9M | +5.3% | -17.9% | -10.9% |
| GWPH | SELL · 10b5-1 | 2019-12-17 | 2019-12-19 | $9.17 | $49K | -3.9% | +12.3% | -26.2% |
| GWPH | SELL | 2019-05-28 | 2019-05-30 | $15.24 | $2.2M | +2.5% | -0.7% | -19.8% |
| GWPH | SELL | 2019-05-28 | 2019-05-30 | $15.24 | $3.1M | +2.5% | -0.7% | -19.8% |
| GWPH | SELL | 2019-03-15 | 2019-03-19 | $14.01 | $328K | +0.7% | -6.9% | +1.7% |
| GWPH | SELL | 2019-02-26 | 2019-02-28 | $12.45 | $275K | -1.4% | -3.1% | +4.3% |
| GWPH | SELL | 2019-02-13 | 2019-02-15 | $12.50 | $283K | +14.3% | +12.1% | +20.0% |
| GWPH | SELL | 2019-01-02 | 2019-01-04 | $8.43 | $120K | +15.7% | +32.1% | +45.5% |
| GWPH | SELL | 2019-01-02 | 2019-01-04 | $8.33 | $188K | +15.7% | +32.1% | +45.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.